Search
DeepMind Subsidiary Isomorphic Labs to Launch Human Trials for AI-Designed Medicines
1 day ago /
Read about 0 minute
Author：小编
Isomorphic Labs, a subsidiary spun off from DeepMind, is set to commence human trials for drugs designed with artificial intelligence. Leveraging cutting-edge machine learning algorithms, the company meticulously analyzes biological data, pinpoints drug targets, and crafts innovative compounds to address a wide spectrum of diseases. Now, it stands poised to embark on human testing phases.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
